Product Description
Ibrushil 140s
Ibrushil is a small molecule drug that binds permanently toa protein, Bruton tyrosine kinase (BTK), which is important in B cells. Ibrushilis used to treat B cell cancers like mantle cell lymphoma, chronic lymphocyticleukemia, and Waldenstr ms macroglobulinemia.
Uses:
Mantle-cell lymphoma and blood cancer(chronic lymphocytic leukemia)
Specification
Brand name | Ibrushil |
Active substance | Ibrutinib |
Strength | 140mg |
Category | Anti Cancer |
Manufacturer | Shilpa Medicare Ltd |
Packaging | 120 Capsules |
Product form | Capsules |
FAQs of Ibrushil 140s:
Q: What is Ibrushil 140s?
A: Ibrushil 140s is a medication used to treat mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It contains the active ingredient ibrutinib and comes in the form of capsules.
Q: How many capsules are in a bottle of Ibrushil 140s?
A: There are 120 capsules in a bottle of Ibrushil 140s.
Q: What is the dosage of Ibrushil 140s?
A: The dosage of Ibrushil 140s is 140mg, as per doctor recommendation.
Q: Who can take Ibrushil 140s?
A: Ibrushil 140s is suitable for teenagers, women, adults, and aged persons.
Q: What are the ingredients of Ibrushil 140s?
A: The active ingredient in Ibrushil 140s is ibrutinib.
Q: How should Ibrushil 140s be stored?
A: Ibrushil 140s should be stored in a dry place.